BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 12019102)

  • 41. Silica gel is as effective as acyclovir cream in patients with recurrent herpes labialis: results of a randomized, open-label trial.
    Zschocke I; Reich C; Zielke A; Reitmeier N; Reich K
    J Dermatolog Treat; 2008; 19(3):176-81. PubMed ID: 18569274
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oral acyclovir and herpes labialis: a randomized, double-blind, placebo-controlled study.
    Raborn GW; McGaw WT; Grace M; Tyrrell LD; Samuels SM
    J Am Dent Assoc; 1987 Jul; 115(1):38-42. PubMed ID: 3301980
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Topical acyclovir therapy in patients with recurrent orofacial herpes simplex infections.
    Van Vloten WA; Swart RN; Pot F
    J Antimicrob Chemother; 1983 Sep; 12 Suppl B():89-93. PubMed ID: 6355055
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prophylaxis against herpes labialis with acyclovir cream--a placebo-controlled study.
    Gibson JR; Klaber MR; Harvey SG; Tosti A; Jones D; Yeo JM
    Dermatologica; 1986; 172(2):104-7. PubMed ID: 3512326
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multicenter randomized study of inosine pranobex versus acyclovir in the treatment of recurrent herpes labialis and recurrent herpes genitalis in Chinese patients.
    You Y; Wang L; Li Y; Wang Q; Cao S; Tu Y; Li S; Bai L; Lu J; Wei Z; Chen W; Hao F
    J Dermatol; 2015 Jun; 42(6):596-601. PubMed ID: 25819042
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Infections caused by herpes simplex virus in the immunocompromised host: natural history and topical acyclovir therapy.
    Whitley RJ; Levin M; Barton N; Hershey BJ; Davis G; Keeney RE; Whelchel J; Diethelm AG; Kartus P; Soong SJ
    J Infect Dis; 1984 Sep; 150(3):323-9. PubMed ID: 6090539
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Herpes labialis treatment with acyclovir 5 per cent ointment.
    Raborn GW; McGaw WT; Grace M; Houle L
    J Can Dent Assoc; 1989 Feb; 55(2):135-7. PubMed ID: 2645030
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combined herbal preparation for topical treatment of Herpes labialis.
    Saller R; Büechi S; Meyrat R; Schmidhauser C
    Forsch Komplementarmed Klass Naturheilkd; 2001 Dec; 8(6):373-82. PubMed ID: 11799306
    [TBL] [Abstract][Full Text] [Related]  

  • 49. n-Docosanol 10% cream in the treatment of recurrent herpes labialis: a randomised, double-blind, placebo-controlled study.
    Habbema L; De Boulle K; Roders GA; Katz DH
    Acta Derm Venereol; 1996 Nov; 76(6):479-81. PubMed ID: 8982417
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clinical comparison of two topical antiviral ointments in herpes].
    Makleit L; Nagy M
    Orv Hetil; 1995 Feb; 136(8):417-9. PubMed ID: 7885687
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of herpes labialis by photodynamic therapy: Study protocol clinical trial (SPIRIT compliant).
    La Selva A; Negreiros RM; Bezerra DT; Rosa EP; Pavesi VCS; Navarro RS; Bello-Silva MS; Ramalho KM; Aranha ACC; Braz-Silva PH; Fernandes KPS; Bussadori SK; Horliana ACRT
    Medicine (Baltimore); 2020 Mar; 99(12):e19500. PubMed ID: 32195950
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A randomized, double-blind, placebo-controlled study to test the efficacy of topical 2-hydroxypropyl-Beta-cyclodextrin in the prophylaxis of recurrent herpes labialis.
    Senti G; Iannaccone R; Graf N; Felder M; Tay F; Kündig T
    Dermatology; 2013; 226(3):247-52. PubMed ID: 23816977
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Current management and recommendations for access to antiviral therapy of herpes labialis.
    Cunningham A; Griffiths P; Leone P; Mindel A; Patel R; Stanberry L; Whitley R
    J Clin Virol; 2012 Jan; 53(1):6-11. PubMed ID: 21889905
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Randomized clinical study comparing Compeed cold sore patch to acyclovir cream 5% in the treatment of herpes simplex labialis.
    Karlsmark T; Goodman JJ; Drouault Y; Lufrano L; Pledger GW;
    J Eur Acad Dermatol Venereol; 2008 Nov; 22(10):1184-92. PubMed ID: 18462303
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Can clinical trials requiring frequent participant contact be conducted over the Internet? Results from an online randomized controlled trial evaluating a topical ointment for herpes labialis.
    Formica M; Kabbara K; Clark R; McAlindon T
    J Med Internet Res; 2004 Feb; 6(1):e6. PubMed ID: 15111272
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevention of ulcerative lesions by episodic treatment of recurrent herpes labialis: A literature review.
    Harmenberg J; Oberg B; Spruance S
    Acta Derm Venereol; 2010 Mar; 90(2):122-30. PubMed ID: 20169294
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effectiveness of topical corticosteroids in addition to antiviral therapy in the management of recurrent herpes labialis: a systematic review and meta-analysis.
    Arain N; Paravastu SC; Arain MA
    BMC Infect Dis; 2015 Feb; 15():82. PubMed ID: 25887308
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recurrent herpes labialis: efficacy of topical therapy with penciclovir compared with acyclovir (aciclovir).
    Femiano F; Gombos F; Scully C
    Oral Dis; 2001 Jan; 7(1):31-3. PubMed ID: 11354919
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thermographic resolution of the prodromal phase of herpes labialis treated with acyclovir.
    Lamey PJ; Biagioni PA
    Dentomaxillofac Radiol; 1995 Aug; 24(3):201-3. PubMed ID: 8617397
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Topical undecylenic acid for herpes simplex labialis: a multicenter, placebo-controlled trial.
    Shafran SD; Sacks SL; Aoki FY; Tyrrell DL; Schlech WF; Mendelson J; Rosenthal D; Gill MJ; Bader RL; Chang I
    J Infect Dis; 1997 Jul; 176(1):78-83. PubMed ID: 9207352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.